Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study
Summary: Background: Gabapentin, opioids, and/or benzodiazepines are commonly prescribed for a variety of pain and psychiatric conditions. Despite the high likelihood of co-prescription of these medications, little is known about co-utilization of gabapentin (GABA), opioids (OP), and benzodiazepines...
Saved in:
Main Authors: | Abisola Olopoenia (Author), Wendy Camelo-Castillo (Author), Danya M. Qato (Author), Adepeju Adekoya (Author), Frank Palumbo (Author), Leah Sera (Author), Linda Simoni-Wastila (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007-2015
by: Danya M. Qato, et al.
Published: (2021) -
Concurrent Prescription Fills of Opioids and Benzodiazepines Among Postpartum Women During COVID-19
by: Amanda J. Abraham, PhD, et al.
Published: (2024) -
Opioid-Induced Hyperalgesia in Chronic Pain Patients and the Mitigating Effects of Gabapentin
by: Nicoleta eStoicea, et al.
Published: (2015) -
Reflections on 'Decolonizing' Big Data in Global Health
by: Danya M. Qato
Published: (2022) -
Concurrent opioid and alcohol withdrawal management
by: Michelle Colvard, PharmD, BCPP
Published: (2023)